Burning Rock Valuation

BNR Stock  USD 6.16  0.85  16.01%   
At this time, the firm appears to be overvalued. Burning Rock Biotech shows a prevailing Real Value of $4.23 per share. The current price of the firm is $6.16. Our model approximates the value of Burning Rock Biotech from analyzing the firm fundamentals such as Current Valuation of 4.58 M, return on equity of -0.69, and Profit Margin of (1.11) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Burning Rock's valuation include:
Price Book
0.6758
Enterprise Value
4.6 M
Enterprise Value Ebitda
(0.17)
Price Sales
0.1068
Enterprise Value Revenue
0.0651
Overvalued
Today
6.16
Please note that Burning Rock's price fluctuation is very risky at this time. Calculation of the real value of Burning Rock Biotech is based on 3 months time horizon. Increasing Burning Rock's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Burning stock is determined by what a typical buyer is willing to pay for full or partial control of Burning Rock Biotech. Since Burning Rock is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Burning Stock. However, Burning Rock's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  6.16 Real  4.23 Target  3.96 Hype  6.41 Naive  5.96
The intrinsic value of Burning Rock's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Burning Rock's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
4.23
Real Value
13.06
Upside
Estimating the potential upside or downside of Burning Rock Biotech helps investors to forecast how Burning stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Burning Rock more accurately as focusing exclusively on Burning Rock's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
0.326.4115.24
Details
Naive
Forecast
LowNext ValueHigh
0.125.9614.79
Details
1 Analysts
Consensus
LowTarget PriceHigh
3.603.964.40
Details
Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Burning Rock's intrinsic value based on its ongoing forecasts of Burning Rock's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Burning Rock's closest peers.

Burning Rock Cash

923.04 Million

Burning Valuation Trend

Burning Rock's real value is important for investors to make better decisions and a more accurate overall view of Burning Rock's financial worth over time. Using both Burning Rock's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.

Burning Revenue by Product

Burning Rock Total Value Analysis

Burning Rock Biotech is currently estimated to have company total value of 4.58 M with market capitalization of 54.42 M, debt of 12.32 M, and cash on hands of 1.15 B. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Burning Rock fundamentals before making security assessment based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
4.58 M
54.42 M
12.32 M
1.15 B

Burning Rock Investor Information

About 61.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.68. Some equities with similar Price to Book (P/B) outperform the market in the long run. Burning Rock Biotech recorded a loss per share of 7.63. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 15th of May 2024. Based on the analysis of Burning Rock's profitability, liquidity, and operating efficiency, Burning Rock Biotech is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.

Burning Rock Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Burning Rock has an asset utilization ratio of 51.68 percent. This connotes that the Company is making $0.52 for each dollar of assets. An increasing asset utilization means that Burning Rock Biotech is more efficient with each dollar of assets it utilizes for everyday operations.
 
Covid

Burning Rock Ownership Allocation

The market capitalization of Burning Rock Biotech is $54.42 Million. Over half of Burning Rock's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.

Burning Rock Profitability Analysis

The company reported the last year's revenue of 537.43 M. Reported Net Loss for the year was (653.69 M) with profit before taxes, overhead, and interest of 380.04 M.

About Burning Rock Valuation

The stock valuation mechanism determines Burning Rock's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Burning Rock Biotech based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Burning Rock. We calculate exposure to Burning Rock's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Burning Rock's related companies.
Last ReportedProjected for Next Year
Gross Profit363.2 M298.8 M
Pretax Profit Margin(1.21)(1.27)
Operating Profit Margin(1.25)(1.31)
Net Loss(1.22)(1.28)
Gross Profit Margin 0.68  0.55 

Burning Rock Growth Indicators

Investing in growth stocks can be very risky. If the company such as Burning Rock does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding10.2 M

Burning Rock Current Valuation Indicators

Burning Rock's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Burning Rock's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Burning Rock, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Burning Rock's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Burning Rock's worth.

Additional Tools for Burning Stock Analysis

When running Burning Rock's price analysis, check to measure Burning Rock's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burning Rock is operating at the current time. Most of Burning Rock's value examination focuses on studying past and present price action to predict the probability of Burning Rock's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burning Rock's price. Additionally, you may evaluate how the addition of Burning Rock to your portfolios can decrease your overall portfolio volatility.